DBV Technologies to delay 10-K filing (6.82 +0.62)
- The Registrant has been delayed in completing the preparation of its Annual Report on Form 10-K for the year ended December 31, 2024 (the "Form 10-K"). The Registrant has been working to secure financing through a private placement to fund the continued development of the Viaskin Peanut program to finance the preparation and submission of the Biologics License Application ("BLA") and to finance the launch readiness and commercialization preparation of Viaskin Peanut in the United States (the "Financing"), as detailed in the Registrant's Current Report on Form 8-K (File No. 001-36697) filed with the Securities and Exchange Commission (the "SEC") on March 31, 2025.
- The Registrant has spent a considerable amount of time and effort on discussions and negotiations with respect to the Financing. In addition, the Registrant is currently assessing the impact that the Financing will have on the disclosures in the Form 10-K regarding the adequacy of its liquidity for the next twelve months as required by generally accepted accounting principles and SEC disclosure requirements.
- These discussions, negotiations and assessments have diverted significant management time and resources from the Company's processes for reviewing and completing its financial statements and related disclosures in a manner that would permit timely filing of the Form 10-K without unreasonable effort or expense. As such, the Registrant's auditors have not yet been able to complete their review of the Form 10-K.